Clear Search
A Prospective, Phase 2, Multicenter, Open-label, Randomized, Comparative Study to Estimate the Safety, Tolerability, Pharmacokinetics, and Effcacy of Oral SCY-078 vs. Standard-of-Care Following Initial Intravenous Echinocandin Therapy in the Treatment of Invasive Candidiasis (including Candidemia) in Hospitalized Non-neutropenic Adults (Mycoses Study Group 010)

A Prospective, Phase 2, Multicenter, Open-label, Randomized, Comparative Study to Estimate the Safety, Tolerability, Pharmacokinetics, and Effcacy of Oral SCY-078 vs. Standard-of-Care Following Initial Intravenous Echinocandin Therapy in the Treatment of Invasive Candidiasis (including Candidemia) in Hospitalized Non-neutropenic Adults (Mycoses Study Group 010)

P. Pappas, J. Pullman, G. Thompson, W. Powderly, A. Spec, E. Tobin, J. Vazquez, S. Wring, D. Angulo, S. Helou, and the Investigators of the Mycoses Study Group
27th European Congress of Clinical Microbiology and Infectious Diseases
April 2017